ATOX™ ComboPen®
(atropine and obidoxime injection)
(NOT available in the USA)
NSN: 6505-21-896-3322
Delivers: 220 mg obidoxime chloride plus 2 mg atropine sulfate in 2 mL
Indications: Antidote for organophosphorous (nerve agent/insecticide) poisoning
Packaged: 100 auto-injectors/box
Export License: Required
ComboPen®
is
a
registered
trademark of Meridian Medical
Technologies™,
Inc. in the United States of America.
ATOX™
is
a
trademark of Meridian Medical
Technologies™,
Inc. in the United States of America.
IMPORTANT SAFETY INFORMATION: Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments including masks designed specifically for this use. Individuals should not rely solely upon antidotes such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Seek immediate medical attention after injection with antidotes.